David W. Hein

Q: What Schools Are Affiliated With David W. Hein

David W. Hein is affiliated with the following schools: University of California, Berkeley, University of Louisville, University of Michigan, Morehouse School of Medicine, University of California, San Francisco, University of North Dakota

David W. Hein's AcademicInfluence.com Rankings

David W. Hein

Medical

#717

World Rank

#949

Historical Rank

#259

USA Rank

Toxicology

#11

World Rank

#13

Historical Rank

USA Rank

Pharmacology

#99

World Rank

#128

Historical Rank

#24

USA Rank

medical Degrees

Download Badge

Medical

David W. Hein's Degrees

PhD Pharmacology University of California, San Francisco
Bachelors Toxicology University of California, Berkeley

Why Is David W. Hein Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David W. Hein is an American professor and scientist. He currently is a Distinguished University Scholar at the University of Louisville where he serves as the Peter K. Knoefel Endowed Chair of Pharmacology and Professor & Chair of the Department of Pharmacology & Toxicology.

(See a Problem?)

David W. Hein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Metabolic gene polymorphism frequencies in control populations. (2001) (915)
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. (2000) (657)
N-acetylation pharmacogenetics. (1985) (634)
Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. (2002) (491)
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses (2005) (468)
Nomenclature for N-acetyltransferases. (1995) (378)
Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. (1993) (359)
Acetylator genotype and arylamine-induced carcinogenesis. (1988) (336)
Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. (2003) (228)
Clinical Pharmacokinetics of Isoniazid (1979) (189)
N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk (2006) (185)
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. (2008) (166)
Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling (2009) (150)
N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. (1999) (144)
A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. (2000) (144)
Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. (2001) (137)
Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions. (1995) (134)
Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. (1994) (130)
N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. (2000) (115)
Update on consensus arylamine N-acetyltransferase gene nomenclature. (2000) (114)
Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. (2008) (114)
Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. (2003) (111)
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. (2011) (111)
Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. (2006) (111)
Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. (2002) (110)
Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. (2007) (99)
Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. (2012) (97)
N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. (2000) (96)
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2. (2008) (95)
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. (2014) (91)
Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. (1984) (91)
Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. (2000) (91)
NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. (2003) (85)
Identification of N-Acetyltransferase 2 (NAT2) Transcription Start Sites and Quantitation of NAT2-Specific mRNA in Human Tissues (2007) (84)
Variability in drug metabolizing enzyme activity in HIV-infected patients (2010) (83)
Human N-acetylation of benzidine: role of NAT1 and NAT2. (1996) (82)
Novel Human N-Acetyltransferase 2 Alleles That Differ in Mechanism for Slow Acetylator Phenotype* (1999) (81)
N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. (2009) (79)
Narcotic discrimination in pigeons. (1980) (77)
Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey. (1981) (71)
Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases. (1997) (70)
Meat Intake, Heterocyclic Amine Exposure, and Metabolizing Enzyme Polymorphisms in Relation to Colorectal Polyp Risk (2008) (68)
Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1. (2001) (68)
Changes in consensus arylamine N-acetyltransferase gene nomenclature. (2008) (67)
Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol. (1989) (66)
Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. (2004) (66)
Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification. (1995) (65)
A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. (1982) (64)
Role of the renin‐angiotensin system in hepatic ischemia reperfusion injury in rats (2004) (64)
Identification of a novel allele at the human NAT1 acetyltransferase locus. (1997) (64)
Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, Poland. (2001) (63)
Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2'-dimethyl-4-aminobiphenyl. (1999) (63)
Association of prostate cancer with rapid N‐acetyltransferase 1 (NAT1*10) in combination with slow N‐acetyltransferase 2 acetylator genotypes in a pilot case‐control study (2002) (62)
Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma. (2006) (61)
Metabolic activation of aromatic and heterocyclicN-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases (2007) (60)
A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background (2010) (60)
Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes. (2001) (60)
Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype. (2000) (59)
Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer (2008) (58)
The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. (2004) (58)
Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma (2006) (57)
Functional Analysis of the Human N-Acetyltransferase 1 Major Promoter: Quantitation of Tissue Expression and Identification of Critical Sequence Elements (2007) (57)
Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. (1993) (57)
Hair dye use and risk of bladder cancer in the New England bladder cancer study (2011) (56)
N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. (2003) (56)
Tissue distribution of N‐acetyltransferase 1 and 2 catalyzing the N‐acetylation of 4‐aminobiphenyl and O‐acetylation of N‐hydroxy‐4‐aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster (2006) (54)
Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse. (1999) (54)
Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. (1997) (54)
Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among Men of African Descent: A case-control study (2009) (54)
Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1 (2006) (53)
A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. (1997) (51)
Skin metabolism of aminophenols: human keratinocytes as a suitable in vitro model to qualitatively predict the dermal transformation of 4-amino-2-hydroxytoluene in vivo. (2009) (51)
Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1). (2004) (50)
Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1. (2002) (50)
GSTM 1 null and NAT 2 slow acetylation genotypes , smoking intensity and bladder cancer risk : results from the New England bladder cancer study and NAT 2 meta-analysis (2011) (50)
N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine (2009) (49)
Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye. (2004) (49)
Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients. (1991) (49)
Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. (1995) (46)
Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts. (2006) (45)
Effects of single nucleotide polymorphisms in human N‐acetyltransferase 2 on metabolic activation (O‐acetylation) of heterocyclic amine carcinogens (2006) (44)
Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. (1991) (43)
GSTM1 Null Genotype, Red Meat Consumption and Breast Cancer Risk (The Netherlands) (2004) (43)
Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. (1994) (43)
Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells* (2015) (43)
Structure-Function Analyses of Single Nucleotide Polymorphisms in Human N-Acetyltransferase 1 (2008) (43)
Acetyltransferases and susceptibility to chemicals. (1992) (42)
Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains. (1982) (42)
Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. (2007) (41)
Functional effects of single nucleotide polymorphisms in the coding region of human N-acetyltransferase 1 (2008) (41)
Molecular Genetics and Epidemiology of the NAT 1 and NAT 2 Acetylation Polymorphisms 1 (2000) (40)
2‐amino‐1‐methyl‐6‐phenylimidazo [4,5‐b] pyridine‐induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N‐acetyltransferase 2 (2007) (40)
Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. (2007) (39)
Relationship of acetylator status to isoniazid toxicity, lupus erythematosus, and bladder cancer. (1983) (39)
Effect of acetylator genotype on 3,2'-dimethyl-4-aminobiphenyl induced aberrant crypt foci in the colon of hamsters. (1996) (39)
Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster. (1985) (39)
Acetylator Phenotype and Genotype in HIV‐Infected Patients with and without Sulfonamide Hypersensitivity (2002) (39)
Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma (2007) (38)
Biochemical evidence for the coexistence of monomorphic and polymorphic N-acetyltransferase activities on a common protein in rabbit liver. (1982) (37)
Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase. (1987) (37)
Manganese superoxide dismutase V16A single-nucleotide polymorphism in the mitochondrial targeting sequence is associated with reduced enzymatic activity in cryopreserved human hepatocytes. (2009) (36)
Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse. (1988) (35)
Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. (1991) (34)
The chemical form of selenium influences 3,2'-dimethyl-4-aminobiphenyl-DNA adduct formation in rat colon. (1999) (34)
Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predisposition. (2002) (34)
Computational and Experimental Analyses of Mammalian Arylamine N-Acetyltransferase Structure and Function (2007) (33)
Haplotype of N-Acetyltransferase 1 and 2 and Risk of Pancreatic Cancer (2007) (33)
Codominant Expression of N-Acetylation and O-Acetylation Activities Catalyzed by N-Acetyltransferase 2 in Human Hepatocytes (2010) (33)
No apparent association between genetic polymorphisms (-102 C>T) and (-9 T>C) in the human manganese superoxide dismutase gene and gastric cancer(1). (2005) (33)
2-Amino-3,8-Dimethylimidazo-[4,5-f]Quinoxaline–Induced DNA Adduct Formation and Mutagenesis in DNA Repair–Deficient Chinese Hamster Ovary Cells Expressing Human Cytochrome P4501A1 and Rapid or Slow Acetylator N-Acetyltransferase 2 (2007) (32)
Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2'-dimethyl-4-aminobiphenyl. (1996) (32)
Effects of dietary factors and the NAT2 acetylator status on gastric cancer in Koreans (2009) (32)
Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster. (1996) (30)
Association of the Histamine N‐Methyltransferase C314T (Thr105Ile) Polymorphism with Atopic Dermatitis in Caucasian Children (2008) (30)
Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer (2012) (29)
Genetic and small molecule inhibition of arylamine N‐acetyltransferase 1 reduces anchorage‐independent growth in human breast cancer cell line MDA‐MB‐231 (2018) (29)
Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations. (2009) (28)
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium (2012) (28)
Identification and Characterization of Functional Rat Arylamine N-Acetyltransferase 3: Comparisons with Rat Arylamine N-Acetyltransferases 1 and 2 (2006) (28)
Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2 (2007) (28)
Symposium overview: the role of genetic polymorphism and repair deficiencies in environmental disease. (1999) (27)
Genetic profiling of colon cancer (2002) (27)
Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase. (1990) (27)
Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens. (1994) (26)
Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus. (1991) (26)
Folate-dependent hydrolysis of acetyl-coenzyme A by recombinant human and rodent arylamine N-acetyltransferases (2015) (26)
Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned. (2007) (26)
Association between acetylator genotype and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) DNA adduct formation in colon and prostate of inbred Fischer 344 and Wistar Kyoto rats. (2000) (26)
N-Acetyltransferase (Nat) 1 and 2 Expression in Nat2 Knockout Mice (2006) (25)
Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism. (1990) (25)
The impact of NAT2 acetylator genotype on mutagenesis and DNA adducts from 2-amino-9H-pyrido[2,3-b]indole. (2009) (25)
Para‐phenylenediamine and allergic sensitization: risk modification by N‐acetyltransferase 1 and 2 genotypes (2009) (25)
Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival (2006) (24)
Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice. (2012) (24)
Interaction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps. (2013) (24)
Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine N-acetyltransferase 1 (2016) (23)
Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters. (1994) (23)
Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol. (1989) (23)
Clinical pharmacogenetics in pediatric patients. (2007) (23)
NATb/NAT1*4 promotes greater arylamine N‐acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4‐aminobiphenyl (2012) (23)
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls (2004) (23)
Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2'-dimethyl-4-aminobiphenyl. (1997) (23)
Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli. (1994) (23)
Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol. (1989) (22)
Human acetylator genotype: Relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol (2005) (22)
NAT2 slow acetylation and GSTM1 null genotypes increase bladder cancer risk: results from the Spanish Bladder Cancer Study and meta-analyses (2008) (21)
N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women. (2009) (21)
Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions. (2011) (21)
Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system (2008) (21)
4,4′-Methylenedianiline-Induced Hepatotoxicity Is Modified by N-Acetyltransferase 2 (NAT2) Acetylator Polymorphism in the Rat (2006) (21)
A New Model for Toxic Risk Assessments: Construction of Homozygous Rapid and Slow Acetylator Congenic Syrian Hamster Lines (1991) (21)
Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes (2017) (21)
Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct. (2012) (20)
Controlling incision-induced distortion of nasal septal cartilage: a model to predict the effect of scoring of rabbit septa. (2003) (19)
Knockout of human arylamine N‐acetyltransferase 1 (NAT1) in MDA‐MB‐231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity (2018) (19)
Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional characterization of a novel rNat3*2 genetic variant. (2007) (19)
Simultaneous determination of 7 N-acetyltransferase-2 single-nucleotide variations by allele-specific primer extension assay. (2006) (19)
Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx). (2010) (18)
Quantitative Tissue and Gene-Specific Differences and Developmental Changes in Nat1, Nat2, and Nat3 mRNA Expression in the Rat (2008) (18)
Retrospective analysis of estrogen receptor 1 and N-acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines (2018) (17)
Inheritance of acetylator genotype-dependent arylamine N-acetyltransferase in hamster bladder cytosol. (1987) (17)
Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenyl. (1999) (16)
Extrahepatic expression of N-acetylator genotype in the inbred hamster. (1987) (16)
Systemic Functional Expression of N-Acetyltransferase Polymorphism in the F344 Nat2 Congenic Rat (2008) (16)
N-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell Lines (2019) (16)
METHODS FOR AROMATIC AND HETEROCYCLIC AMINE CARCINOGEN-DNA ADDUCT ANALYSIS BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (2008) (16)
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats. (2000) (16)
Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adducts (2009) (15)
CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism (2020) (15)
Narcotic drug discriminations by rhesus monkeys and pigeons. (1979) (15)
Effect of N-Acetyltransferase 2 Polymorphism on Tumor Target Tissue DNA Adduct Levels in Rapid and Slow Acetylator Congenic Rats Administered 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (2009) (15)
Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes (2017) (15)
Phenotype of the Most Common “Slow Acetylator” Arylamine N-Acetyltransferase 1 Genetic Variant (NAT1*14B) Is Substrate-Dependent (2012) (15)
Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism (2017) (15)
Inheritance of liver N-acetyltransferase activity in the rapid and slow acetylator inbred hamster. (1985) (14)
No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer. (2003) (14)
Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon (2004) (14)
Functional Genomics of C190T Single Nucleotide Polymorphism in Human N-Acetyltransferase 2 (2002) (14)
Genetic polymorphism and cancer susceptibility: Evidence concerning acetyltransferases and cancer of the urinary bladder (1988) (14)
Using gene-environment interaction analyses to clarify the role of well-done meat and heterocyclic amine exposure in the etiology of colorectal polyps. (2012) (14)
2-Aminofluorene-DNA adduct levels in tumor-target and nontarget organs of rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus. (1996) (14)
N-acetyltransferase single nucleotide polymorphisms: Emerging concepts serve as a paradigm for understanding complexities of personalized medicine (2009) (13)
Expression and genotype‐dependent catalytic activity of N‐acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1 (2018) (13)
Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review. (2018) (13)
The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster. (1986) (13)
Metabolic Gene Polymorphism Frequencies in Control Populations 1 (2001) (13)
Daily Rhythm in Plasma N-acetyltryptamine (2017) (13)
No Association Between Variant N-acetyltransferase Genes, Cigarette Smoking and Prostate Cancer Susceptibility Among Men of African Descent (2011) (13)
Role of Human N‐Acetyltransferase 2 Genetic Polymorphism on Aromatic Amine Carcinogen‐Induced DNA Damage and Mutagenicity in a Chinese Hamster Ovary Cell Mutation Assay (2020) (12)
Manganese Superoxide Dismutase Expression as a Function of Genotype and Lung Cancer Pathology (2010) (12)
Identification and inheritance of inbred hamster N-acetyltransferase isozymes in peripheral blood. (1986) (12)
High N-Acetyltransferase 1 Expression is Associated with Estrogen Receptor Expression in Breast Tumors, but is not Under Direct Regulation by Estradiol, 5α-androstane-3β, 17β-Diol, or Dihydrotestosterone in Breast Cancer Cells (2018) (12)
Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib. (2008) (12)
DNA adduct levels and intestinal lesions in congenic rapid and slow acetylator syrian hamsters admi food mutagens 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). (2000) (12)
Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma (2009) (12)
An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitro. (1981) (12)
Method for determination of (-102C>T) single nucleotide polymorphism in the human manganese superoxide dismutase promoter (2004) (11)
3,2'-Dimethyl-4-aminobiphenyl-DNA adduct formation in tumor target and nontarget organs of rapid and slow acetylator Syrian hamsters cogenic at the NAT2 locus. (1996) (11)
Metabolic activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian hamsters congenic at the N-acetyltransferase 2 (NAT2) locus. (2003) (11)
Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene. (1992) (11)
4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats. (2008) (10)
Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review (2020) (10)
N-Acetyltransferase 2 Genotype-Dependent N-Acetylation of Hydralazine in Human Hepatocytes (2017) (10)
DNA adduct levels and absence of tumors in female rapid and slow acetylator congenic hamsters administered the rat mammary carcinogen 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (2001) (10)
Relationship between N-acetyltransferase 2 single-nucleotide polymorphisms and phenotype. (2010) (9)
Oral administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) yields PhIP-DNA adducts but not tumors in male Syrian hamsters congenic at the N-acetyltransferase 2 (NAT2) locus. (2001) (9)
Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate Cancer (2015) (8)
Lack of Association of the N-acetyltransferase NAT1*10 Allele with Prostate Cancer Incidence, Grade, or Stage Among Smokers in Finland (2011) (8)
Quinoxaline – Induced DNA Adduct Formation and Mutagenesis in DNA Repair – Deficient Chinese Hamster Ovary Cells Expressing Human Cytochrome P 4501 A 1 and Rapid or Slow Acetylator N-Acetyltransferase 2 (2007) (8)
Identification and characterization of potent, selective, and efficacious inhibitors of human arylamine N-acetyltransferase 1 (2021) (8)
Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype (2018) (8)
Acetylator genotype-dependent formation of 2-aminofluorene-hemoglobin adducts in rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus. (1994) (8)
Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes (2020) (8)
Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster. (2003) (7)
Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbit. (1984) (7)
Acetylator genotype-dependent N-acetylation of arylamines in vivo and in vitro by hepatic and extrahepatic organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus (2006) (7)
Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study (2012) (7)
N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes (2019) (6)
Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes (2020) (6)
Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action. (1982) (6)
An Alternative Cyclin-D1 Splice Site is Not Linked to Inflammatory Bowel Disease-Associated Neoplasia (2010) (6)
Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase. (1982) (6)
Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence in general population. (2008) (6)
DISCRIMINATIVE AND REINFORCING EFFECTS OF SOME SYSTEMICALLY ACTIVE ENKEPHALIN ANALOGUES (1980) (5)
Arylamine N-Acetyltransferase Type 2 Polymorphism and Human Urinary Bladder and Breast Cancer Risks (2018) (5)
Rabbit N-acetyltransferase 2 genotyping method to investigate role of acetylation polymorphism on N- and O-acetylation of aromatic and heterocyclic amine carcinogens (2017) (5)
Role of the N-acetylation polymorphism in solithromycin metabolism. (2017) (5)
Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes (2022) (5)
Correction: Acetylator phenotype and genoype in patients infected with HIV: Discordance between methods for phenotype determination and genotype (Pharmacogenetics (2000) 10 (171-182)) (2000) (5)
Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and healthcare disparities. (2004) (5)
Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4′-methylenedianiline (2019) (4)
Design and Success of a 21st Century Cancer Education Program at the University of Louisville (2018) (4)
Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2 (2022) (4)
Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation. (2018) (3)
Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for N-Acetyltransferase 2 (2020) (3)
Identification of L‐Asparagine as a Novel Endogenous Substrate for Human Arylamine N‐Acetyltransferase 1 (2017) (3)
Deletion of arylamine N‐acetyltransferase 1 in MDA‐MB‐231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis (2022) (3)
Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes. (1995) (3)
TaqMan Real Time–Polymerase Chain Reaction Methods for Determination of Nucleotide Polymorphisms in Human N‐Acetyltransferase‐1 (NAT1) and ‐2 (NAT2) (2004) (3)
N-Acetyltransferase 1 (Nat1) and 2 (Nat2) expression in Nat2 knockout mice (2006) (3)
A four-SNP NAT2 genotyping panel recommended to infer human acetylator phenotype (2012) (3)
Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis (2022) (3)
Transcriptional Regulation of Human Arylamine N-Acetyltransferase 2 Gene by Glucose and Insulin in Liver Cancer Cell Lines. (2022) (3)
DNA adduct levels in rapid and slow acetylator inbred rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. (1997) (3)
Phenotypic and Genotypic Characterization of N -Acetylation (2005) (3)
Phase I/II dose-escalation trial of amonafide for treatment of advanced solid tumors: Genotyping to optimize dose based on polymorphic metabolism (2007) (3)
Genetic regulation of acetyltransferases in the Syrian inbred hamster: a model for man. (1990) (2)
REVISION CARCIN-2008-00096 Interaction of the Cytochrome P4501A2, SULT1A1 and NAT Gene Polymorphisms with Smoking and Dietary Mutagen Intake in Modification of the Risk of Pancreatic Cancer (2007) (2)
Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype (2017) (2)
Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype (2017) (2)
Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens (2022) (2)
Acetyl CoA:arylamine N-acetyltransferase activity in rat hepatocytes cultured on different extracellular matrices. (1997) (1)
Chemoprevention of Arylamine-Induced Colorectal Aberrant Crypts (2008) (1)
The protective effect of celecoxib, a cyclooxygenase-2 inhibitor, on aberrant crypt formation in rats administered 3,2’-dimethyl-4-aminobiphenyl (2006) (1)
560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment (2022) (1)
Partial purification of acetylator phenotype-dependent and independent hamster bladder isozymes with metabolic capacity towards carcinogenic arylamines (1986) (1)
Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype (2017) (1)
Genetic Polymorphism of N -Acetyltransferase Genes as Risk Modifiers of Colorectal Cancer from Consumption of Well-Done Meat (2006) (1)
The Human Arylamine N-Acetyltransferase Type 2 Gene: Genomics and Cardiometabolic Risk (2018) (1)
Recombinant expression and catalytic analysis of rapid and slow acetylator Syrian hamster chimeric NAT2 alleles (1997) (1)
Association of arylhydroxamic acid N,O-acyltransferase and genetically polymorphic N-acetyltransferase in established inbred rabbit strains. (1982) (1)
SCREENING METHOD FOR URINARY BLADDER TUMOR DETECTION IN THE SYRIAN HAMSTER (1999) (1)
Hexavalent chromium increases the metabolism and genotoxicity of aromatic amine carcinogens 4-aminobiphenyl and β-naphthylamine in immortalized human lung epithelial cells. (2022) (1)
Functional effects of N‐acetyltransferase 1 (NAT1*10) polymorphisms (2009) (1)
Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant (2022) (1)
Acetylator Genotype-Dependent Metabolic Activation of N-Hydroxy-2-Aminofluorene in Syrian Hamster Lines Congenic at the NAT2 Locus (1994) (1)
Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells. (2022) (1)
Identification and Characterization of Novel Arylamine NAcetyltransferase Small Molecule Inhibitors (2012) (1)
Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells. (2022) (1)
N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes (2022) (1)
Influence of N‐acetyltransferase polymorphism in the N‐acetylation of asparagine and putrescine (2022) (1)
A phase I pharmacokinetic, pharmacogenomic trial of weekly amonafide in patients (pts) with solid tumors. (2004) (1)
Simultaneous Determination of 7 N-Acetyltransferase-2 Sequence Variations by Allele-Specific Primer Extension Assay (2006) (1)
Childhood Secondhand Tobacco Smoke Exposure and Ovarian Reserve Among Females Seeking Fertility Care, and Interaction with N- Acetyltransferase 2(NAT2) Genotype (2018) (1)
Heterocyclic amines reduce insulin-induced AKT phosphorylation and induce gluconeogenic gene expression in human hepatocytes. (2023) (0)
Stable Isotope Tracing Reveals an Altered Fate of Glucose in N-Acetyltransferase 1 Knockout Breast Cancer Cells (2023) (0)
Changes in Insulin Signaling and Gluconeogenic Gene Expression in Human Hepatocytes Following Exposure to Heterocyclic Amines (2021) (0)
Non-coding and intergenic genetic variants of human arylamine N-acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders (2023) (0)
Relationship of Syrian inbred hamster acetylator genotype to the mutagenic activation of 2-aminofluorene. (1990) (0)
Inheritance pattern of N-acetyltransferase in hamster liver (1985) (0)
Genetic regulation of N-acetyltransferase in target organs of arylamine tumors: homologous expression in human and hamster bladder and colon. (1991) (0)
Loss of Manganese Superoxide Dismutase Expression in Pancreatic Cancer Carcinogenesis (2010) (0)
Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes (2020) (0)
Conspectus 2.8.2.1 :: Search Results (2013) (0)
N-acetyltransferaseSNPs:emerging conceptsserveasaparadigmfor understandingcomplexitiesof personalizedmedicine (2009) (0)
Author's response to reviews Title: Association between polymorphic glutathione S-transferase (GST) genes, their combination and interaction with tobacco smoke and prostate cancer risk: A case-control study (2009) (0)
Effect of N-acetyltransferase 2 genetic polymorphism on 4,4'-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stress. (2023) (0)
Interaction among Carcinogen‐biotransformation Genes (N‐acetyltransferase 1 and 2) and Prostate Cancer Risk Using a Comprehensive Analytical Approach (2007) (0)
Functional effects of human N‐acetyltransferase‐2 (NAT2) single nucleotide polymorphisms (SNPs) on the activation of arylamine carcinogens (2007) (0)
Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism (2017) (0)
Pharmacogenomics: Social, Ethical, and Clinical Dimensions (2003) (0)
Effects of dose and human N-acetyltransferase 1 genetic polymorphism in benzidine metabolism and genotoxicity. (2023) (0)
Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes (2017) (0)
Design and Success of a 21st Century Cancer Education Program at the University of Louisville (2016) (0)
Significantly higher 2‐amino‐3,8‐dimethylimidazo‐[4,5‐f]quinoxaline–induced DNA adducts and mutagenesis in Chinese hamster ovary cells expressing human CYP1A1 and rapid or slow acetylator N‐acetyltransferase 2 (2007) (0)
Microsoft Word-84522533-file00 (2011) (0)
Biochemical basis of N-acetyltransferase polymorphism in hamster liver (1985) (0)
Structure homology modeling of human arylamine N‐acetyltransferases: Computational and experimental approaches (2007) (0)
Microsoft Word-21991679-file00 (2009) (0)
Referees for Volume 41 (2004) (0)
Quantitation and characterization of N‐acetyltransferase‐2 mRNA in human tissues (0)
Surgical outcomes of non-periprosthetic distal femur fragility fractures treated with a locking plate (2022) (0)
Motivating Young Investigators to Pursue Cancer Research Careers and Training (2016) (0)
First year cohort results for the NCI R25 University of Louisville Cancer Education Program (2013) (0)
Abstract 4817: Using the Mendelian randomization approach to clarify the role of well-done meat and heterocyclic amine exposure in the etiology of colorectal polyps (2012) (0)
Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells (2022) (0)
Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine N-acetyltransferase 1 (2016) (0)
Abstract 4037: The effects of n-acetyltransferase 1 gene knockout on the cytotoxicity of pyrimidine biosynthesis inhibitors in human breast cancer cells (2022) (0)
Stable expression of human cytochrome P450 1A1, human NADPH-cytochrome p450 reductase and single copy of human N-acetyltransferase-2 in DNA nucleotide excision repair-deficient Chinese hamster ovary cells (2004) (0)
Differences in the CNS toxicity of isoniazid between rapid and slow acetylator rabbits (1980) (0)
OII‐C‐2 (2006) (0)
A rapid and sensitive method for detection of urinary bladder tumors in rodents. (1998) (0)
In memoriam: Wendell W. Weber, PhD, MD (1925-2018). (2018) (0)
4 – Pharmacogenetics: Pharmacogenomics (2017) (0)
Combined Effects of Variant N‐Acetyltranserase 1 (NAT1) and Multiple Drug Resistance 1 (MDR1) Genes in Prostate Cancer Risk (2007) (0)
Acetylator genotype -dependent metabolic activation of 2-hydroxy-amino-1-methyl-6-phenylimidazo pyridine by mammary epithelial cells derived from rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus (2000) (0)
- Acetyltransferase O-Hydroxyarylamine-N Hamster : Identity with Polymorphic-Acetyltransferase from Homozygous Rapid Acetylator Inbred N Purification of Hepatic Polymorphic Arylamine Updated (2006) (0)
Title Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy : A case control study (2012) (0)
Association between cigarette smoking and ovarian reserve among women seeking fertility care (2021) (0)
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium (2012) (0)
Human rapid acetylator N‐acetyltransferase 2 (NAT2) genotype leads to greater mutagenesis and DNA damage than slow acetylator NAT2 genotype in DNA‐deficient Chinese Hamster Ovary (CHO) cells treated with arylamine carcinogens (2007) (0)
Para-phenylenediamine and allergic sensitization: Risk modificationbyn-acetylation (2007) (0)
Genetic variation in N-acetylation of arylamine drugs and carcinogens in the inbred hamster (1981) (0)
Abstract B77: Translational effects of alternative NAT1 mRNA isoforms (2008) (0)
Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer (2012) (0)
N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances (2022) (0)
Rabbit N-acetyltransferase 2 genotyping method to investigate role of acetylation polymorphism on N- and O-acetylation of aromatic and heterocyclic amine carcinogens (2017) (0)
Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4′-methylenedianiline (2019) (0)
N-acetylation capacity of N-acetyltransferase 2 in human peripheral blood mononuclear cells regulated by NAT2 genotype and sirtuin 1 (2019) (0)
Metabolic Activation of yV-Hydroxy-2-aminofluorene and 7V-Hydroxy-2-acetylaminofluorene by Monomorphic W-Acetyltransferase (NATI) and Polymorphic W-Acetyltransferase (NAT2) in Colon Cytosols of Syrian Hamsters Congenie at the NAT2 Locus1 (2006) (0)
Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status (2022) (0)
A phase I pharmacokinetic, pharmacogenomic trial of weekly amonafide in patients (pts) with solid tumors (2004) (0)
The Role of Arylamine N‐acetyltransferase 1 in Breast Cancer Progression (2013) (0)

This paper list is powered by the following services:

Other Resources About David W. Hein

en.wikipedia.org

What Schools Are Affiliated With David W. Hein?

David W. Hein is affiliated with the following schools:

David W. Hein's Academic­Influence.com Rankings

David W. Hein's Degrees

Why Is David W. Hein Influential?

David W. Hein's Published Works

Published Works

Other Resources About David W. Hein

What Schools Are Affiliated With David W. Hein?

David W. Hein's AcademicInfluence.com Rankings